Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis. 2022

Marcela Ávila, and Ma Del Carmen Prado, and Renata Romero, and Ricardo Córdova, and Ma Del Carmen Rigo, and Miguel Trejo, and Carmen Mora, and Ramón Paniagua, and For The Mexican Nephrology Collaborative Study Group
Unidad de Investigación Médica en Enfermedades Nefrológicas, Hospital de Especialidades, CMN SXXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.

The purpose of this study was to compare vascular calcification (VC), serum osteoprotegerin (OPG) levels, and other biochemical markers to determine their value as available predictors of all-cause and cardiovascular (CV) mortality in patients on peritoneal dialysis (PD). A total of 197 patients were recruited from seven dialysis centers in Mexico City. VC was assessed with multi-slice computed tomography, measured using the calcification score (CaSc). OPG, albumin, calcium, hsC-reactive protein, phosphorous, osteocalcin, total alkaline phosphatase, and intact parathormone were also analyzed. Follow-up and mortality analyses were assessed using the Cox regression model. The mean age was 43.9 ± 12.9 years, 64% were males, and 53% were diabetics. The median OPG was 11.28 (IQR: 7.6−17.4 pmol/L), and 42% of cases had cardiovascular calcifications. The median VC was 424 (IQR:101−886). During follow-up (23 ± 7 months), there were 34 deaths, and 44% were cardiovascular in origin. In multivariable analysis, OPG was a significant predictor for all-cause (HR 1.08; p < 0.002) and CV mortality (HR 1.09; p < 0.013), and performed better than VC (HR 1.00; p < 0.62 for all-cause mortality and HR 1.00; p < 0.16 for CV mortality). For each mg/dL of albumin-corrected calcium, there was an increased risk for CV mortality, and each g/dL of albumin decreased the risk factor for all-cause mortality. OPG levels above 14.37 and 13.57 pmol/L showed the highest predictive value for all-cause and CV mortality in incident PD patients and performed better than VC.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000418 Albumins Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating. Albumin
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Marcela Ávila, and Ma Del Carmen Prado, and Renata Romero, and Ricardo Córdova, and Ma Del Carmen Rigo, and Miguel Trejo, and Carmen Mora, and Ramón Paniagua, and For The Mexican Nephrology Collaborative Study Group
January 2013, PloS one,
Marcela Ávila, and Ma Del Carmen Prado, and Renata Romero, and Ricardo Córdova, and Ma Del Carmen Rigo, and Miguel Trejo, and Carmen Mora, and Ramón Paniagua, and For The Mexican Nephrology Collaborative Study Group
January 2018, Kidney & blood pressure research,
Marcela Ávila, and Ma Del Carmen Prado, and Renata Romero, and Ricardo Córdova, and Ma Del Carmen Rigo, and Miguel Trejo, and Carmen Mora, and Ramón Paniagua, and For The Mexican Nephrology Collaborative Study Group
January 2016, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Marcela Ávila, and Ma Del Carmen Prado, and Renata Romero, and Ricardo Córdova, and Ma Del Carmen Rigo, and Miguel Trejo, and Carmen Mora, and Ramón Paniagua, and For The Mexican Nephrology Collaborative Study Group
April 2018, BMC nephrology,
Marcela Ávila, and Ma Del Carmen Prado, and Renata Romero, and Ricardo Córdova, and Ma Del Carmen Rigo, and Miguel Trejo, and Carmen Mora, and Ramón Paniagua, and For The Mexican Nephrology Collaborative Study Group
January 2003, Journal of the American Society of Nephrology : JASN,
Marcela Ávila, and Ma Del Carmen Prado, and Renata Romero, and Ricardo Córdova, and Ma Del Carmen Rigo, and Miguel Trejo, and Carmen Mora, and Ramón Paniagua, and For The Mexican Nephrology Collaborative Study Group
October 2022, Kidney medicine,
Marcela Ávila, and Ma Del Carmen Prado, and Renata Romero, and Ricardo Córdova, and Ma Del Carmen Rigo, and Miguel Trejo, and Carmen Mora, and Ramón Paniagua, and For The Mexican Nephrology Collaborative Study Group
December 2023, Atherosclerosis,
Marcela Ávila, and Ma Del Carmen Prado, and Renata Romero, and Ricardo Córdova, and Ma Del Carmen Rigo, and Miguel Trejo, and Carmen Mora, and Ramón Paniagua, and For The Mexican Nephrology Collaborative Study Group
November 2023, Clinical nutrition (Edinburgh, Scotland),
Marcela Ávila, and Ma Del Carmen Prado, and Renata Romero, and Ricardo Córdova, and Ma Del Carmen Rigo, and Miguel Trejo, and Carmen Mora, and Ramón Paniagua, and For The Mexican Nephrology Collaborative Study Group
March 2014, Renal failure,
Marcela Ávila, and Ma Del Carmen Prado, and Renata Romero, and Ricardo Córdova, and Ma Del Carmen Rigo, and Miguel Trejo, and Carmen Mora, and Ramón Paniagua, and For The Mexican Nephrology Collaborative Study Group
January 2024, Kidney & blood pressure research,
Copied contents to your clipboard!